MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Posterior cortical atrophy (PCA) attributable to corticobasal degeneration

H. Sienkiewicz-Jarosz, E. Bucior (Warsaw, Poland)

Meeting: 2019 International Congress

Abstract Number: 1081

Keywords: Corticobasal degeneration (CBD)

Session Information

Date: Tuesday, September 24, 2019

Session Title: Parkinsonisms and Parkinson-Plus

Session Time: 1:45pm-3:15pm

Location: Agora 3 West, Level 3

Objective: Introduction: PCA is a clinico-radiological syndrome characterized by progressive decline in visual processing and other posterior cognitive functions, relatively intact memory and language in the early stages, and atrophy of posterior brain regions. We present a case of corticobasal degeneration as an example of the PCA-plus syndromes.

Background: Case report: A 72-year-old man with a 5 years history of progressive symptoms of bradykinesia and limb apraxia. His past medical history included cataract surgery and bilateral macular degeneration. He was treated with levodopa in the past, but after introduction of the drug the patient reported only slight and transient improvement of motor function. The neurological examination revealed mainly left-sided bradykinetic-hypertonic syndrome. Moreover, left-sided visual neglect syndrome, visuospatial dysfunction and cortical sensory signs like astereognosis were presented. In addition, the patient had mirror movements of the left upper limb. Neuropsychological assessment revealed significant deficits in visual attention, visual and spatial functions, including the features of visual agnosia, agraphia and apraxia, with relatively intact memory and language functions. A brain magnetic resonance imaging showed asymmetric cortical and subcortical atrophy including mainly parietal lobes.

Method: case report

Results: Discussion: Chronic progressive nature, the asymmetry of symptoms, the lack of response to levodopa, the presence of mirror movements and cortical sensory signs as well as the results of the brain magnetic resonance imaging and neuropsychological assessment were the basis for the suspicion of corticobasal degeneration. Standard physical therapy and occupational therapy is recommended to improve functioning in such cases. The efficacy of levodopa is usually low.

Conclusion: Key words: corticobasal degeneration, atypical parkinsonism, posterior cortical atrophy

To cite this abstract in AMA style:

H. Sienkiewicz-Jarosz, E. Bucior. Posterior cortical atrophy (PCA) attributable to corticobasal degeneration [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/posterior-cortical-atrophy-pca-attributable-to-corticobasal-degeneration/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/posterior-cortical-atrophy-pca-attributable-to-corticobasal-degeneration/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley